Harold J Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared on X:
“Important presentation on anthracyclines and outcomes in TAILORx by OncotypeDX score.
Anthracycline chemo benefit over TC limited to T2 or larger tumors with ODX => 31.
See also our recent JCO ASCO editorial on this topic.”
